Similar articles

• Primary prevention using ICDs may be cost-effective for people with left ventricular systolic dysfunction. Commentary 2.

  Sheldon R. Sheldon R. Evid Based Cardiovasc Med. 2006 Mar;10(1):56-8. doi: 10.1016/j.ebcm.2006.01.036. Evid Based Cardiovasc Med. 2006. PMID: 16530690 No abstract available.
• Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.

  Filion KB, Xie X, van der Avoort CJ, Dendukuri N, Brophy JM. Filion KB, et al. Int J Technol Assess Health Care. 2009 Apr;25(2):151-60. doi: 10.1017/S0266462309090205. Epub 2009 Mar 31. Int J Technol Assess Health Care. 2009. PMID: 19331707
• [Non invasive quantification of the parietal systolic stress of the left ventricle in patients with heart failure and its clinical application].

  Guadalajara Boo JF, González Zárate J, Bucio Reta E, Pérez P, Cué Carpio RJ. Guadalajara Boo JF, et al. Arch Cardiol Mex. 2007 Apr-Jun;77(2):120-9. Arch Cardiol Mex. 2007. PMID: 17715625 Review. Spanish.
• Effectiveness of implantable cardioverter-defibrillators in patients with ischemic heart disease and left ventricular dysfunction.

  Chan PS, Chow T, Kereiakes D, Schloss EJ, Waller T, Eagle K, Hayward RA, Vijan S. Chan PS, et al. Arch Intern Med. 2006 Nov 13;166(20):2228-33. doi: 10.1001/archinte.166.20.2228. Arch Intern Med. 2006. PMID: 17101941
• Device therapies in the post-myocardial infarction patient with left ventricular dysfunction.

  Kadish AH, Reiffel JA, Naccarelli GV, DiMarco JP. Kadish AH, et al. Am J Cardiol. 2008 Sep 8;102(5A):29G-37G. doi: 10.1016/j.amjcard.2008.06.008. Am J Cardiol. 2008. PMID: 18722189 Review.